Results 151 to 160 of about 3,364,808 (342)

Novel Histopathologic Features of Diffuse Blue‐Gray Hyperpigmentation Associated With Kratom Use: A Case Report and Literature Review

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Background Drug‐induced hyperpigmentation accounts for 10%–20% of acquired pigmentary disorders and can be misdiagnosed for other causes such as melasma, post inflammatory changes, or heavy metal deposition. Kratom (Mitragyna speciosa), a Southeast Asian plant with an opioid‐like profile, has been increasingly used in the United States for ...
Rita Kamoua, Kristen Paradine, Craig A. Rohan, Mary McDaniel, Diane Perkins   +4 more
wiley   +1 more source

The Effect of Newer Drugs on Health Spending: Do They Really Increase the Costs? [PDF]

We analyze the influence of technological progress on pharmaceuticals on rising health expenditures using US State level panel data. Improvements in medical technology are believed to be partly responsible for rapidly rising health expenditures.
Civan, Abdülkadir, Koksal, Bulent
core   +1 more source

Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.

Schizophrenia bulletin, 2014
K. Gill, J. Cook, M. Poe, A. Grace
semanticscholar   +1 more source

Association between glucagon‐like peptide‐1 receptor agonists and risk of dementia in older adults with type 2 diabetes: A target trial emulation

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Type 2 diabetes (T2D) is associated with increased dementia risk, but comparative data across newer glucose‐lowering therapies remain limited. We examined whether the initiation of GLP‐1 receptor agonists (GLP‐1 RAs) was associated with incident dementia compared with DPP4 inhibitors (DPP4is) and SGLT2 inhibitors (SGLT2is) in older adults ...
Ting Zhou, Huilin Tang, Bingyu Zhang, Dazheng Zhang, Yiwen Lu, Lu Li, Jiajie Chen, Yong Chen, David A. Asch, Yong Chen   +9 more
wiley   +1 more source

The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells.

Carcinogenesis, 2013
S. Shin, K. Lee, Y. Choi, H. Lim, H. Lee, Y. Lim, Young Han Lee   +6 more
semanticscholar   +1 more source

Mental health changes after 4 months of weight loss treatment with the glucagon‐like peptide‐1 analogue liraglutide 3.0 mg

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Objective This observational study examined changes in mental health and wellbeing after 4‐months liraglutide 3.0 mg treatment in patients with obesity and explored associations with weight loss. Methods We included 98 patients with obesity treated with liraglutide 3.0 mg.
Susanne Kuckuck, Nina van Gerwen, Johanneke E. Oosterman, Mesut Savas, Maryam Kavousi, Brenda W. J. H. Penninx, Mariëtte R. Boon, Elisabeth F.C. van Rossum   +7 more
wiley   +1 more source

Emerging treatments in the management of schizophrenia – focus on sertindole

Drug Design, Development and Therapy, 2010
Maria Rosaria A Muscatello, Antonio Bruno, Gianluca Pandolfo, Umberto Micò, Salvatore Settineri, Rocco ZoccaliSection of Psychiatry, Department of Neurosciences, Psychiatric and Anaesthesiological Sciences, University of Messina, ItalyAbstract:
Maria Rosaria A Muscatello, Antonio Bruno, Gianluca Pandolfo, et al   +3 more
doaj  

Evaluation of SYA16263 as a new potential antipsychotic agent without catalepsy. [PDF]

Pharmacol Biochem Behav, 2019
Bricker BA, Peprah K, Kang HJ, Ablordeppey SY.   +3 more
europepmc   +1 more source

Parkinson's Disease and Salivary Issues: A Survey

Gerodontology, EarlyView.
ABSTRACT Background Salivary dysfunction, including xerostomia and drooling, is common in Parkinson's disease and further impairs oral health and quality of life, which are already compromised in this population. Their effective management demands deeper insight into the complexity of salivary dysfunction.
Beau D. M. van Dijk, Merel C. Verhoeff, Niels van der Aa, Frank Lobbezoo   +3 more
wiley   +1 more source

Chromeno[3,4-c]pyridin-5-ones:  Selective Human Dopamine D₄ Receptor Antagonists as Potential Antipsychotic Agents

, 1997
Paul C. Unangst, Thomas Capiris, David T. Connor, Thomas G. Heffner, Robert G. MacKenzie, S.R. Miller, Thomas A. Pugsley, Lawrence D. Wise   +7 more
openalex   +1 more source